Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872348 · ClinicalTrials.gov registry record
An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
A clinical trial, sponsored by Sight Sciences.
- Completed
- Registry status
- 28
- Enrollment target
NCT04872348 is a clinical trial that has completed, run by Sight Sciences. The registered enrollment target is 28 participants.
The verdict
NCT04872348 has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the OMNI® Surgical System in subjects who have undergone canaloplasty and trabeculotomy using OMNI® Surgical System without any concomitant surgery in pseudophakic eyes with mild to moderate primary open angle glaucoma (POAG) at least 150 days prior to enrollment.
Interventions
- DEVICE OMNI® Surgical System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04872348
The ClinicalTrials.gov registry entry for NCT04872348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OMNI® Surgical System is the first listed.
NCT04872348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04872348 about?
NCT04872348 is a clinical study titled "An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)". The purpose of this study is to evaluate the safety and effectiveness of the OMNI® Surgical System in subjects who have undergone canaloplasty and trabeculotomy using OMNI® Surgical System without any concomitant surgery in pseudophakic eyes with mild to moderate primary open angle glaucoma (POAG) a...
What is the current status of trial NCT04872348?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-07-01. Estimated completion is 2023-11-02.
What interventions are being tested in trial NCT04872348?
The interventions under investigation include: OMNI® Surgical System (DEVICE).
Who is sponsoring clinical trial NCT04872348?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.